Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genaissance Pharmaceuticals (GNSC) -- Ignore unavailable to you. Want to Upgrade?

To: Bob Trocchi who wrote (14)	3/9/2001 8:41:13 PM
From: Jim Oravetz	Read Replies (1) \| Respond to of 183

Bob, thanks for joining in. Yes, not much action here. There are others that have posted elsewhere in biotech land on GNSC, who have not done so here. I live near New Haven and as indicted in the header to the thread, I also follow VION, CRGN, ALXS and Neurogen (NGEN?). I have not invested in GNSC yet, although I have some holdings in VION and CRGN. (Certainly my engineering background allows be to be more knowledgable on the ADI thread.) I have not dug too deep into this company, but the direction of customizing medicines to individuals seems promissing. Not sure how FDA trials/approvals would be handled with such an approach. They seem to be pretty well funded so far. Jim